secwatch / observer
8-K filed June 16, 2023, 7:59 PM ET ticker VBIO CIK 0001787740
other confidence high sentiment negative materiality 0.70

Tivic Health shareholders reject reverse stock split proposal; Dean Zikria elected director

Valion Bio, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Valion Bio, Inc. shareholders approved Ratification of Rosenberg Rich Baker Berman, P.A. as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-14 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-14
Exact text from the filing
The Company’s stockholders ratified the selection of Rosenberg Rich Baker Berman, P.A. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, as follows: Votes For Votes Against Abstentions Broker Non-Votes 15,466,407 727,906 116,035 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Valion Bio, Inc. shareholders approved Election of Class II Director at the 2023-06-14 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-14
Exact text from the filing
The Company’s stockholders elected one Class II director, to hold office until the Company’s 2026 annual meeting of stockholders, or until his successor is duly elected and qualified, subject to prior death, resignation or removal, as follows: Name of Director Votes For Votes Against Abstentions Broker Non-Votes Dean Zikria 9,216,549 0 916,197 6,177,602
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Valion Bio, Inc. shareholders rejected Authorize amendment to certificate of incorporation to effect a reverse stock split at a ratio between 1-for-5 and 1-for-30 at the 2023-06-14 meeting.

Proposal
reverse split
Outcome
failed
Meeting
2023-06-14
Exact text from the filing
The Company’s stockholders did not approve the Company’s proposal to authorize the Company to amend its amended and restated certification of incorporation to effect, at the discretion of its Board, a reverse stock split of all of the Company’s issued and outstanding shares of common stock at a ratio of not less than 1-for-5 and not greater than 1-for-30, such ratio to be determined by its Board at any time within twelve months, without further approval or authorization of its stockholders, as follows: Votes For Votes Against Abstentions Broker Non-Votes 14,000,037 2,153,285 157,026 0
View on SEC.gov

63 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Valion Bio, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-23-028676
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.